Market News

Cleaver Scientific has supplied a UV Sterilization Cabinet to Touchlight Genetics (Hampton, UK) who had sought a sterile workspace for the preparation of their RNA and DNA samples and templates.

Perrigo will immediately commence its previously announced $2 billion repurchase of Perrigo shares and plans to complete $500 million of the planned repurchase by the end of 2015.

Exiting four sites to optimise capacity utilisation will affect approximately 1,200 positions.

Four independent production lines to support clinical batch production and commercial scale manufacturing.

Daewoong has secured exclusive rights in Korea and Thailand to sell both the original product and to register and market all the new formulations, based on Erdosteine, which are currently under development at Edmond Pharma.

The MBO will support future growth by driving innovations for customers and building new strategic partnerships to further expand market position as a leader in host cell assay development.

The company now offeres the first nine antibodies in its Validated Antibody programme which are H3, RNA pol II (S), RNA pol II (S5), H3K9me3, 5mC, AcH3, AcH4, AR and Sin3a

The vaccines division of Sanofi presents at the World Vaccine Congress in Spain.

Six major launches expected to generate aggregate peak sales of €12 billion to €14 billion.

High elasticity and crack bridging ensure durability of the membrane even in contact with unstable substrates.

Company’s fifth formulation plant and the second API Plant.

Company on track to deliver its 25% revenue growth target for this year.

Global leadership position in specialty amines strengthened.

Sterile manufacturing specialist Symbiosis Pharmaceutical Services has appointed Joanne Anderson as its new Business Development Director to help drive its commercial growth.

Describes general principles and a recommended format for inspection reports for use by organizations performing pharmaceutical inspections.

The facility will produce medicines for the treatment of diabetes and obesity.

The system offers parallel processing and walk-away control of 24 micro bioreactors.

The new Syrina 2.25 is one of the most compact versions of auto-injector available today utilising the standard 2.25 mL PFS, based on Bespak’s proprietary VapourSoft technology.

New building to feature collaboration-focused workspace.

Strengthens BMS’s pipeline and strategic focus on heart failure.

Lead pipeline product, DX-2930, is a Phase III-ready asset, offering potentially transformative prophylactic therapy for HAE.

AMSBIO launches a range of recombinant prokaryotic lectins.

Allegations concerning the activities of Philidor raise questions about the company’s business practices.

Under the settlement agreements, Warner Chilcott Sales will pay a total of approximately $102 million, plus interest, to the federal government and the states to resolve civil claims.

Trastuzumab development and transfer for first Indonesian on-site production.

Team honored for its innovative approach to the scientific discovery and development of its PD-1 immune checkpoint inhibitor, Opdivo, in the treatment of advanced melanoma and squamous non-small cell lung cancer.

Sanofi has received 26 reports of suspected device malfunctions in the US and Canada.

First commercial CAPGo-derived laminin, LN-521, expected to be globally available in 2016.

Collaboration will utilize Affinivax’s novel MAPS Vaccine Technology Platform.

Instrumentation using uses FMS for headspace oxygen analysis of biopharmaceutical container closure systems, and icIEF for analysis of charge distribution and heterogeneity in biopharmaceuticals

The new expansion also includes new dedicated receiving, dispatch and packaging areas.

Rx-360’s first CEO will lead the consortium to its next phase of growth.

Pollutants and contaminants can now be detected at previously undetectable levels.

Titan Enterprise's latest issue of fLowdown highlights differential flowmeters.

Transaction includes the European Union, Switzerland, Turkey and the Commonwealth of Independent States.

AstraZeneca's anti-PD-L1 immune checkpoint inhibitor, durvalumab (MEDI4736), will be combined with Lilly molecules that target the immune system.

Management team completes buy out of specialist ion channel research business from Xention.

Corporate restructuring to result in an 11% workforce reduction.

Merck Millipore to provide Provantage End-to-End solution for development and manufacture of biosimilars.

In a clinical study, patients report significant reduction in dry eye symptoms in just 30 days of usage.

Wetteny Joseph chosen to lead the company’s Clinical Supply Services Business.

Faster flow rates than most sterilizing-grade filters, reducing footprint.

The company’s $224 million investment in the development, is the largest foreign investment in the construction of a new pharmaceutical facility in the country.

With four programs currently in clinical trials and five more expected to enter the clinic by the end of 2016, Novartis has rapidly built a robust portfolio of programs focused on stimulating the body's immune system to combat cancers.

Raheen site will be largest capacity biopharmaceutical production facility in Ireland.

Acquisition will create a platform for further growth into emerging markets.

Expansion of Bioprocess Solutions stronger than expected yet again; positive development in Lab Products & Services.

Company plans to refile lifitegrast submission in the first quarter of 2016.

Company to outsource all existing and future clinical and commercial manufacturing operations.

The facility will be engineered to enable to work with highly potent APIs and moisture-sensitive compounds.

XEN45 approved in global markets and in in late-stage development in the US.

The new medium is chemically-defined, animal component free, and has been specifically designed to support sustained, high growth with increased transfection efficiency that can yield gram-scale protein expression.

The company reorganizes its US Commercial operations to support upcoming specialty pipeline.

Xcelodose enables Juniper Pharma Services to accurately fill API directly into capsules

Commemorative bottles specially labelled to denote the batch containing the four billionth bottle were produced for the occasion.

The OptiShell softgel technology uses plant-derived polysaccharides providing scientists with new formulation opportunities.

New state-of-the-art manufacturing facility will include areas dedicated to bioconjugation, formulation, purification, quality control, and aseptic fill finish including lyophilization.

Seven prestigious and worthy winners picked from over 70 entries.

New S80 film features consistent cell growth, robustness and high quality.

Merck Serono and Merck Millipore become Merck

CPHI expert warns without urgent regulatory change improving quality is a fool’s game.

CPHI experts warn USA trade laws are too heavily in favour of big pharma

CPHI experts predict continuous manufacturing for all within 10-years, but the raw material black swans have not gone away.

A powerful binder designed to avoid peroxide formation.

The chromatographic tool of choice for in-process and final control of IgG purified from cell culture supernatant or human plasma.

The online drug development course provides an interactive platform for students to explore the fundamental principles of drug development, learn about the regulatory environment that govern the biopharmaceutical industry, and identify the roles of key...

The enhancements help drug product manufacturers meet their own internal quality guidelines as well as those recently published by the European Commission.

He will be responsible for all aspects of construction of the Suzhou manufacturing facility, and will lead manufacturing operations for BeiGene’s small-molecules, including production, engineering, quality operations, supply chain and logistics.

Expansion will power immuno-oncology discovery and research collaborations.

One of the largest pharmacy benefit managers to provide access to cholesterol-lowering medication Repatha (evolocumab) for millions of patients in need.

Horizon will exploit its translational genomics and combination sciences platform to define optimum approaches to treatment and identify cancer patient populations most likely to respond.

Manufacturers plan to implement premium pricing strategies for commercial use of albumin as an excipient.

$2.575 billion spent on a provider of compounded sterile preparations to strengthen AmerisourceBergen’s core business.

‘Enterprise Zone’ Building will house company’s expanding R&D operation.

Protein supplement for gamete and embryo manipulation in assisted reproduction.

The company is preparing for commercialization of this product through Impax's generic division.

Services include feasibility studies, process and analytical development and scale-up.

Agreement with BioMarin, a leading company in the treatment of genetic and rare diseases, also includes returning option to develop and commercialize Peg-Pal.

Kybella first FDA-approved non-surgical injection for submental fullness bolsters Allergan's facial aesthetics portfolio.

The FTC filed its amicus brief in a private antitrust action in which Mylan Phamraceuticals Inc. alleges that Warner Chilcott PLC/Mayne Pharma Group maintained a monopoly in the market for its antibiotic Doryx by suppressing generic competition through...

NGF antibody fasinumab currently in Phase II/III osteoarthritis trial.

Demand in Latin America region fuels double-digit sales growth in Q2 2015.

ADCC-enhancement for innovative cancer therapy, produced via ProBioGen’s accelerated CMC development path.

Selected APIs, such as ibuprofen, omega-3 fatty acids and polyethylenglycol (PEG), where the company has a leading market position, will remain a key part of BASF’s portfolio.

The new centre will provide companies with open access facilities and expertise to help them develop, prove and commercialise new and improved processes and technologies for biologics manufacture.

Closing of transaction expected within next 2 months.

Expansion includes a new commercial spray dryer unit, which will be specifically designed to handle potent APIs

Fifth anniversary of the first commercial ADC (Adcetris) sees Piramal introduce ‘Proof of Concept’ service for next wave of ADC growth.

Chemotherapy is evolving to include biomarker-driven remedies based on the molecular mutations of tumours, finds Frost & Sullivan.

Research and Markets announces the addition of the "ADC Contract Manufacturing Market (2nd edition), 2015–2025" report to their offering.

SMEs predicted to be main beneficiaries.

Pending final FDA approval, Basaglar can be launched in the US beginning on 15 December 2016.

Genovate's target is to become China's first and the world's fourth largest insulin manufacturer.

Ruling bars generic versions of Vyvanse from entering market until patents expire.

Allergan is the first company to receive FDA approval for and launch a generic version of Janssen's Invega.

The new outstation will provide life science researchers with the company's proprietary DigiWest multiplex protein profiling services, to accelerate lead characterisation, disease mechanism and drug mode-of-action analyses, as well as biomarker identif...

Technological developments allow the new washers to deliver enhanced drying performance from an upgraded dual fan system incorporated in the washer chambers.

Acquisition will add a leader in pharmaceutical distribution across the Republic of Ireland and Northern Ireland to McKesson’s European business.

The plant will manufacture FlexPen prefilled devices.

The plans include a multifunctional preclinical research facility and a state-of-the-art biologics manufacturing facility.

Envigo has been created through the integration of Huntingdon Life Sciences, Harlan Laboratories, GFA, NDA Analytics and LSR associates.

HHS will provide initial funding of approximately $17 million to support preclinical development and antibody manufacturing. This initial funding is designed to support an Investigational New Drug application with the FDA.

Girish Malhotra believes the pharmaceutical industry should be allowed to commercialise process improvements without regulatory re-approval.

Frost & Sullivan webinar reveals stem cell therapy pipeline and treatments innovating regenerative medicine.

The 5-year base subcontract covers studies to improve the manufacturing process and establish long-term storage of MVA-BN Filo bulk vaccine. The contract also includes options for an additional USD 24 million to implement process development activities...

Pharmaceutical professionals must develop wider commercial and business skills if they want to continue to secure the top jobs, according to NonStop Recruitment.

Dezima's lead molecule is TA-8995, an oral, once-daily cholesteryl ester transfer protein (CETP) inhibitor.

Genevac has developed a suite of proprietary technological solutions to facilitate post purification sample handling, including reformatting.

The terms of the license cover commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line, developed by Horizon and adapted to manufacturing conditions by LakePharma.

The LakeCentre facility, located in Boulder, Colorado will increase manufacturing and production capacity to support the company’s extensive portfolio of biologics medicines.

Industry experts identify and address common problems encountered during modern tablet production from punch and die design, to tooling specification and aftercare.

The investment comes as the CDMO pharmaceutical sector is expected to grow significantly in the next 5 years.

The company’s sepsis therapy has the potential to be used not only in combination with existing antibiotics, but also to treat patients when conventional therapeutic options are not available.